viernes, 15 de enero de 2016

Dengue Vaccine Enters Phase 3 Trial in Brazil

NIAID Logo

Thursday, Jan. 14, 2016

Dengue Vaccine Enters Phase 3 Trial in Brazil

mosquito

An experimental dengue vaccine developed by NIAID researchers is now being tested in a large-scale clinical trial in Brazil. There were more than 1.5 million cases of dengue fever recorded in Brazil last year.

Read More

No hay comentarios:

Publicar un comentario